Examples of Definitive Financing Agreement in a sentence
In furtherance and not in limitation of the foregoing waiver, it is acknowledged and agreed that no Financing Source shall have any liability for any claims or damages to the Company (prior to the Closing) in any way relating to this Agreement, the Financing, the Debt Letters or the Definitive Financing Agreement, the performance thereof or any other transactions contemplated hereby or thereby.
No party has any claim or remedy in respect of a warranty, statement, misrepresentation (whether negligent or innocent) or undertaking made to it by or on behalf of another party in connection with or relating to the Contemplated Transactions which is not expressly included in a Transactional Agreement, Definitive Financing Agreement or Merger Agreement.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that Joint Venture Agreement or Definitive Financing Agreement, among the Company and Gamma executed concurrently herewith.
Notwithstanding anything to the contrary in this Agreement, 46 it is explicitly agreed that the Company shall be a third party beneficiary of the Equity Financing Commitment Letter (or if superseded thereby, any Definitive Financing Agreement related thereto).
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that Definitive Financing Agreement, among the Company and Holder executed concurrently herewith.
The Definitive Financing Agreement dated January 14, 2011 and the Common Stock Purchase Warrant of even date thereof are hereby rescinded, voided and of no force and effect, as if they had never been entered into.
Replacement of Section 11.1(g) ($5,000,001 of Net Tangible Assets at Closing) with New Section 11.1(g) (Definitive Financing Agreement).
On January 14, 2011, Spectral, through its subsidiary Extractive and IAHC entered into that certain Definitive Financing Agreement (“DFA”) whereby Spectral agreed to acquire a 65% interest in the Mining Contract in exchange for a financing commitment of $200,000,000 at no more than a 10% annual interest rate to be provided within 60 months of the date thereof.
On the third and final day of the symposium, Dr. Rakesh Jain presented an overview of renal tumor physiology and described fac tors such as heterogeneity in tumor blood flow, intratumor pressure, and leukocyte-endothelial interactions within tumor vasculature that may affect the efficacy of various therapeutic modalities.
Each party agrees and acknowledges that it has not relied on or been induced to enter into a Transactional Agreement, Definitive Financing Agreement or Merger Agreement, by a warranty, statement, representation or undertaking which is not expressly included in a Transactional Agreement, Definitive Financing Agreement, or Merger Agreement.